The opportunity
Teva has made a commitment to be a leader in biosimilars. The position is critical in helping to build and manage Teva’s biosimilar franchise. The position is responsible driving pricing and customer strategies across the inline, launches and pipeline in collaborations with the business leaders for launches and pipeline. The position leads the inline business, currently consisting of two established biosimilar brands TRUXIMA® and HERZUMA®.
Location: This is a hybrid role (3 days in office/week) based in Parsippany, NJ.
How you’ll spend your day
All areas of responsibility listed below are essential to the satisfactory performance of this position by any incumbents with reasonable accommodation if necessary. Any non-essential functions are assumed to be included in other related duties or assignments.
Go-To-Market Strategy Leadership for Biosimilars
Collaborates with launch and pipeline management to establish go-to-market models for launches focusing on customer specific strategies identifying and strategizing for future sources of business.
Collaborates with customer facing teams’ leadership (including market access, GPO, trade, specialty pharmacy, and IDN) on an ongoing basis to facilitate brand strategy execution and reports learnings back to the wider biosimilars marketing team for strategic adjustments.
Leads collaboration efforts across all commercial customer facing teams ensuring pricing strategy compliance to achieve short term and long-term financial objectives.
Collaborates closely with market access teams on payer strategy and pull through.
Collaborates with trade teams on specialty pharmacy strategy with focus on interchangeability.
Pricing Strategy Leadership for Biosimilars
Develops pricing strategies for future biosimilar launches across medical and pharmacy benefit in collaboration with launch and pipeline leadership, market access and account management.
Is an expert on customer economics and ensures relevant insights are incorporated into go-to-market strategies.
Strong understanding of the 340b space and ability to strategize around value maximization for biosimilars in the space.
Inline Portfolio Leadership for Biosimilars
Leads inline brand management for TRUXIMA and HERZUMA, two oncology buy-and-bill biosimilars
Collaborates on marketing plan and tactics with marketing operations for TRUXIMA and HERZUMA
Applies strategies to establish long-term sustainability considering pricing, reimbursement, customer mix and 340b dynamics.
Other Strategic Responsibilities
Collaborates with the matrix biosimilars marketing team as well as with the wider cross-functional team to deliver on set objectives.
Supports market research to enable future launches and support inline products in collaboration with the insights team, analyzes market data and information and makes informed decisions.
Leads Business Development assessments for future biosimilar products.
Understands and stays up to date with biosimilar policy matters and supports Teva’s government affairs teams in driving policy changes as well as collaborates with other biosimilars marketing leaders incorporating key policy (e.g. IRA).
Leads/Supports strategic projects on biosimilars.
Aligns organizationally and individually with internal and external codes of conduct.
Collaborates with Teva’s global biosimilars team on strategic matters.
